Start­up with Johns Hop­kins roots rais­ing $40.5 mil­lion to de­vel­op can­cer me­tab­o­lism drugs

A new on­col­o­gy com­pa­ny spun out of Johns Hop­kins School of Med­i­cine is rais­ing up to $40.5 mil­lion to de­vel­op its plat­form of an­ti­cancer ther­a­pies …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA